SCHEMBL16048877

SCHEMBL16048877

CCCC(=O)CCCCCCCC(=O)OC

nearest known ligand 0.58

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.58
LMNA P02545 4/20 0.52
ALDH1A1 P00352 1/20 0.52
KMT2A Q03164 2/20 0.48
MAPT P10636 1/20 0.48
EPHX2 P34913 1/20 0.47
POLB P06746 1/20 0.47
POLA1 P09884 1/20 0.47
DGKA P23743 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.45
CA12 O43570 2/20 0.44
CA14 Q9ULX7 2/20 0.44
CA2 P00918 1/20 0.44
CA7 P43166 1/20 0.44
CA9 Q16790 1/20 0.44
HAO1 Q9UJM8 1/20 0.44
KDM5A P29375 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6821580 0.93 TSHR (0.68) TSHRLMNAALDH1A1KMT2AMAPT
SCHEMBL3621835 0.91 MAPT (0.59) TSHRLMNAALDH1A1KMT2AMAPT
SCHEMBL6415465 0.91 MAPT (0.59) TSHRLMNAALDH1A1KMT2AMAPT
SCHEMBL16046101 0.91 MAPT (0.59) TSHRLMNAALDH1A1KMT2AMAPT
SCHEMBL12192678 0.91 MAPT (0.59) TSHRLMNAALDH1A1KMT2AMAPT
SCHEMBL7112187 0.91 MAPT (0.59) TSHRLMNAALDH1A1KMT2AMAPT
SCHEMBL20637044 0.91 MAPT (0.59) TSHRLMNAALDH1A1KMT2AMAPT
SCHEMBL40101 0.91 MAPT (0.59) TSHRLMNAALDH1A1KMT2AMAPT
SCHEMBL19816815 0.91 MAPT (0.59) TSHRLMNAALDH1A1KMT2AMAPT
SCHEMBL3033282 0.91 MAPT (0.59) TSHRLMNAALDH1A1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2970813-B1 MALEINIZED ESTER DERIVATIVES WILMAR TRADING PTE LTD (SG) 2022-12-14 EP disclosed
US-9481850-B2 Maleinized ester derivatives ELEVANCE RENEWABLE SCIENCES, INC. (US) 2016-11-01 US disclosed
US-9464255-B2 Maleinized ester derivatives ELEVANCE RENEWABLE SCIENCES, INC. (US) 2016-10-11 US disclosed
US-20160215233-A1 Maleinized Ester Derivatives ELEVANCE RENEWABLE SCIENCES, INC. (US) 2016-07-28 US disclosed
US-20160200999-A1 Maleinized Ester Derivatives ELEVANCE RENEWABLE SCIENCES, INC. (US) 2016-07-14 US disclosed
EP-2970813-A1 MALEINIZED ESTER DERIVATIVES Elevance Renewable Sciences, Inc. (US) 2016-01-20 EP disclosed
US-20150057204-A1 Maleanized Ester Derivatives ELEVANCE RENEWABLE SCIENCES, INC. (US) 2015-02-26 US disclosed
WO-2014164597-A1 MALEINIZED ESTER DERIVATIVES ELEVANCE RENEWABLE SCIENCES, INC. (US) 2014-10-09 WO disclosed
US-20140274832-A1 MALEINIZED ESTER DERIVATIVES ELEVANCE RENEWABLE SCIENCES, INC. (US) 2014-09-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160200999-A1 Maleinized Ester Derivatives ADH5, MLEC, ADH1A TSHR 4800/4885LMNA 2408/4885ALDH1A1 17/4885
US-20160215233-A1 Maleinized Ester Derivatives ADH5, MLEC, ADH1A TSHR 4800/4885LMNA 2408/4885ALDH1A1 17/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.